Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients
Clinical trial NCT02716272 · COMPLETED
Trial details
- NCT number
- NCT02716272
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-24
- Primary completion
- 2018-02-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.